Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma × Magnetic Resonance Imaging × Clear all

Sponsor

Conditions

Prostatic Neoplasms 8 Breast Neoplasms 7 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Lymphoma, B-Cell 2 Liver Neoplasms 2 Leukemia 2 Carcinoma, Hepatocellular 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Papillomavirus Infections 1 Osteomyelitis 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Sclerosis 1

Interventions

Irinotecan 7 Cyclophosphamide 7 Vincristine 6 Dactinomycin 5 temsirolimus 4 cixutumumab 4 Sirolimus 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 X-Rays 3 Radiation 3 Phantoms, Imaging 3 Doxorubicin 3 thymoglobulin 2 fludarabine phosphate 2 eribulin 2 Vinorelbine 2 Temozolomide 2 Tacrolimus 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Image-Guided 2 Peripheral Blood Stem Cell Transplantation 2 Nuclear Medicine Department, Hospital 2 Nivolumab 2 Melphalan 2 Ifosfamide 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡